Abacus FCF Advisors LLC Acquires 22,105 Shares of Colgate-Palmolive Company $CL

Abacus FCF Advisors LLC lifted its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 11.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 223,175 shares of the company’s stock after purchasing an additional 22,105 shares during the quarter. Colgate-Palmolive accounts for approximately 2.4% of Abacus FCF Advisors LLC’s portfolio, making the stock its 12th largest position. Abacus FCF Advisors LLC’s holdings in Colgate-Palmolive were worth $17,841,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of CL. Baron Wealth Management LLC grew its stake in Colgate-Palmolive by 7.7% in the 3rd quarter. Baron Wealth Management LLC now owns 5,778 shares of the company’s stock worth $462,000 after buying an additional 414 shares in the last quarter. Diversified Trust Co grew its position in Colgate-Palmolive by 12.8% in the third quarter. Diversified Trust Co now owns 96,003 shares of the company’s stock worth $7,674,000 after acquiring an additional 10,892 shares in the last quarter. Mirova US LLC grew its position in Colgate-Palmolive by 50.9% in the third quarter. Mirova US LLC now owns 28,494 shares of the company’s stock worth $2,278,000 after acquiring an additional 9,614 shares in the last quarter. Chemung Canal Trust Co. increased its stake in Colgate-Palmolive by 1.1% in the third quarter. Chemung Canal Trust Co. now owns 18,886 shares of the company’s stock valued at $1,510,000 after acquiring an additional 200 shares during the last quarter. Finally, Annex Advisory Services LLC raised its position in Colgate-Palmolive by 2.4% during the third quarter. Annex Advisory Services LLC now owns 106,068 shares of the company’s stock valued at $8,479,000 after purchasing an additional 2,437 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CL has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft set a $86.00 price objective on Colgate-Palmolive in a report on Friday, October 10th. Morgan Stanley cut their target price on Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating for the company in a research note on Monday, November 3rd. Barclays reduced their price target on shares of Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 4th. JPMorgan Chase & Co. lifted their target price on shares of Colgate-Palmolive from $87.00 to $88.00 and gave the stock an “overweight” rating in a research report on Thursday, December 18th. Finally, Bank of America reduced their price objective on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Ten research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average target price of $88.81.

Colgate-Palmolive Trading Down 0.1%

CL opened at $79.65 on Tuesday. The business has a 50 day simple moving average of $78.52 and a two-hundred day simple moving average of $82.53. The firm has a market capitalization of $64.21 billion, a price-to-earnings ratio of 22.31, a PEG ratio of 5.68 and a beta of 0.30. The company has a debt-to-equity ratio of 5.90, a current ratio of 0.93 and a quick ratio of 0.60. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $100.18.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, October 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. The company had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.17 billion. Colgate-Palmolive had a return on equity of 333.39% and a net margin of 14.47%.The firm’s revenue for the quarter was up 1.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.91 earnings per share. Analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st will be issued a $0.52 dividend. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 annualized dividend and a yield of 2.6%. Colgate-Palmolive’s dividend payout ratio (DPR) is 58.26%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.